Prostatis Group
Prostatis Group reported 200 stocks worth $463M in its 13F filing for Q3 2026, filed Nov 13, 2026. Its largest holdings are THIR (16.4%), DIVO (4.5%) and QQQ (3.2%). Compared with Q2 2026, the fund opened new positions in VO, VB and HIAI, added to THIR, VUG and XNTK, trimmed DIVO, QQQ and PWB and sold out of XOM, IJS and QQQM.
Latest filing: what Prostatis Group did in Q3 2026
vs Q2 2026Dollar changes use the share change at the quarter end price. New and sold out show the whole position.
Portfolio at a glance
share of reported value · Q3 2026Holdings
| # | Stock | Value | Weight | Shares | Change | Shares, 8 qtrs | Held |
|---|---|---|---|---|---|---|---|
| 1 | ![]() THIR Thor Finl Technologies TR | $75.9M | 16.4% | 2.3M | +173K (+8%) | 8 of 8 | |
| 2 | ![]() DIVO Amplify ETF TR | $21M | 4.5% | 452K | −5,498 (−1%) | 8 of 8 | |
| 3 | ![]() QQQ Invesco Qqq TR | $14.9M | 3.2% | 20K | −2,315 (−10%) | 8 of 8 | |
| 4 | ![]() VUG Vanguard Index Fds | $14.4M | 3.1% | 160K | +21K (+15%) | 8 of 8 | |
| 5 | ![]() VO Vanguard Index Fds | $14M | 3.0% | 179K | New position | 1 of 8 | |
| 6 | ![]() XNTK Spdr Series Trust | $14M | 3.0% | 37K | +10K (+39%) | 5 of 8 | |
| 7 | ![]() IGM Ishares TR | $13.7M | 3.0% | 81K | +10K (+15%) | 7 of 8 | |
| 8 | ![]() VTV Vanguard Index Fds | $12.8M | 2.8% | 59K | +38K (+184%) | 8 of 8 | |
| 9 | ![]() IAI Ishares U.s. Broker-Dealers & Securities Exchanges ETF | $9.9M | 2.1% | 56K | +12K (+28%) | 7 of 8 | |
| 10 | ![]() VB Vanguard Index Fds | $9.1M | 2.0% | 32K | New position | 1 of 8 |
Positions at Sep 30, 2026, as reported. Change is against the fund's Q2 2026 filing; weight is the share of the fund's reported stocks.
Sold out
held in Q2 2026, gone in Q3 2026| Stock | Value last quarter | Shares sold |
|---|---|---|
EXCHANGE LISTED FDS TR | $8.3M | 120K |
![]() XOM Exxon Mobil Corp | $3.7M | 27K |
![]() IJS Ishares TR | $2.2M | 16K |
![]() QQQM Invesco Nasdaq | $2.1M | 6,998 |
![]() GSIE Goldman Sachs ETF TR | $2.1M | 46K |
🔒 Free account: see all 27.
Reported value
last 8 quartersThe value of the US stocks the fund reported, at quarter end prices. It moves with the market as well as with buying and selling.
Filings for Q3 2026
straight from the SEC| Filed | Form | Quarter | |
|---|---|---|---|
| Nov 13, 2026 | 13F-HR | Q3 2026 | SEC filing ↗ |
Other superinvestors
All hedge fund holdings →Prostatis Group 13F FAQ
What does Prostatis Group own?
Prostatis Group reported 200 stocks worth $463M in its 13F filing for Q3 2026, filed Nov 13, 2026. Its largest holdings are THIR (16.4%), DIVO (4.5%) and QQQ (3.2%). The table above lists every position in the filing (the top 10 without an account).
What did Prostatis Group buy and sell in Q3 2026?
Compared with Q2 2026: 37 new positions, 101 added to, 57 trimmed and 27 sold out. New positions include VO, VB and HIAI. It sold all of XOM, IJS and QQQM.
When will Prostatis Group file its next 13F?
Holdings as of Dec 31, 2026 are due by Feb 15, 2027. The filing appears on this page within minutes of reaching the SEC.
How much is Prostatis Group's portfolio worth?
The Q3 2026 filing reports $463M in US stocks. That leaves out cash, bonds, short positions and most foreign holdings, so the fund's total assets are usually larger.
For informational and educational purposes only. Not investment advice, and not a recommendation to buy or sell any security. Holdings come from the fund's SEC Form 13F filings as reported and show positions at the end of the quarter, up to 45 days before the filing. The fund may have changed its positions since. A 13F leaves out short positions, cash, bonds and most foreign holdings. See all hedge fund holdings.


HIAI


















